Counterfeit dapoxetine sold on the Internet contains undisclosed sildenafil
Abstract
Abstract\n There is growing problem with medications and herbal products sold via the Internet containing inappropriate quantities or the absence of active ingredients or whose ingredients are inaccurately represented, which may or may not be harmful to the user. We report on a counterfeit medication whose active ingredient is dapoxetine, a short-acting selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. The counterfeit dapoxetine was sold on the Internet and contained an undisclosed phosphodiesterase type 5 inhibitor ingredient. Moreover, the Internet site only sold a 60 mg dose and did not indicate that the recommended starting dose of the medication for all patients is 30 mg.
Read the paper
Related studies
- Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.